CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability

Post time 1 hour(s) ago

journal：Life Sciences

Authors：Mehdi Rabiee Valashedi; Amaneh Mohammadi Roushandeh; Kazuo Tomita; Yoshikazu Kuwahara; Zahra Pourmohammadi-Bejarpasi; Pouya Safarzadeh Kozani; Tomoaki Sato; Mehryar Habibi Roudkenar

Published date：2022-9-

DOI：10.1016/j.lfs.2022.120704

PDF link：https://www.sciencedirect.com/sc ... 024320522004040/pdf

Article link：https://doi.org/10.1016/j.lfs.2022.120704

Article Source：Elsevier BV。

Remark：

Post time 1 hour(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability